Cargando…
Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study
This study aimed to examine the incidence and predictors of loss to follow up (LTFU) in the context of ongoing atrocities caused by armed conflict, where HIV treatment programs and HIV-infected patients may face unique challenges in terms of ART adherence and retention in care. We conducted an obser...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025920/ https://www.ncbi.nlm.nih.gov/pubmed/35457498 http://dx.doi.org/10.3390/ijerph19084631 |
_version_ | 1784690994963283968 |
---|---|
author | Buju, Roger T. Akilimali, Pierre Z. Kamangu, Erick N. Mesia, Gauthier K. Kayembe, Jean Marie N. Situakibanza, Hippolyte N. |
author_facet | Buju, Roger T. Akilimali, Pierre Z. Kamangu, Erick N. Mesia, Gauthier K. Kayembe, Jean Marie N. Situakibanza, Hippolyte N. |
author_sort | Buju, Roger T. |
collection | PubMed |
description | This study aimed to examine the incidence and predictors of loss to follow up (LTFU) in the context of ongoing atrocities caused by armed conflict, where HIV treatment programs and HIV-infected patients may face unique challenges in terms of ART adherence and retention in care. We conducted an observational prospective cohort study of 468 patients living with HIV (PLWHIV) under dolutegravir (DTG) in all health facilities in Bunia between July 2019 and July 2021. Kaplan–Meier plots were used to determine the probability of LTFU as a function of time as inclusive of the cohort. The main outcome variable was LTFU, defined as not taking an ART refill for a period of 3 months or longer from the last attendance for refill, and not yet classified as ‘dead’ or ‘transferred-out.’ The log-rank test was used to compare survival curves based on predictors. Cox proportional hazard modeling was used to measure predictors of LTFU from the baseline until 31 July 2021 (the endpoint). A total of 3435.22 person-months (p-m) were involved in follow up, with an overall incidence rate of 33.48 LTFU per 1000 p-m. Patients who had less experience with ART at enrolment and the ethnically Sudanese, had a higher hazard of being LTFU compared to their reference groups. This study reports a high LTFU rate in this conflict setting. An ART program in such a setting should pay more attention to naive patients and other particularly vulnerable patients such as Sudanese during the pre-ART phase. The study implies the implementation of innovative strategies to address this high risk of being LTFU, reducing either the cost or the distance to the health facility. |
format | Online Article Text |
id | pubmed-9025920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90259202022-04-23 Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study Buju, Roger T. Akilimali, Pierre Z. Kamangu, Erick N. Mesia, Gauthier K. Kayembe, Jean Marie N. Situakibanza, Hippolyte N. Int J Environ Res Public Health Article This study aimed to examine the incidence and predictors of loss to follow up (LTFU) in the context of ongoing atrocities caused by armed conflict, where HIV treatment programs and HIV-infected patients may face unique challenges in terms of ART adherence and retention in care. We conducted an observational prospective cohort study of 468 patients living with HIV (PLWHIV) under dolutegravir (DTG) in all health facilities in Bunia between July 2019 and July 2021. Kaplan–Meier plots were used to determine the probability of LTFU as a function of time as inclusive of the cohort. The main outcome variable was LTFU, defined as not taking an ART refill for a period of 3 months or longer from the last attendance for refill, and not yet classified as ‘dead’ or ‘transferred-out.’ The log-rank test was used to compare survival curves based on predictors. Cox proportional hazard modeling was used to measure predictors of LTFU from the baseline until 31 July 2021 (the endpoint). A total of 3435.22 person-months (p-m) were involved in follow up, with an overall incidence rate of 33.48 LTFU per 1000 p-m. Patients who had less experience with ART at enrolment and the ethnically Sudanese, had a higher hazard of being LTFU compared to their reference groups. This study reports a high LTFU rate in this conflict setting. An ART program in such a setting should pay more attention to naive patients and other particularly vulnerable patients such as Sudanese during the pre-ART phase. The study implies the implementation of innovative strategies to address this high risk of being LTFU, reducing either the cost or the distance to the health facility. MDPI 2022-04-12 /pmc/articles/PMC9025920/ /pubmed/35457498 http://dx.doi.org/10.3390/ijerph19084631 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Buju, Roger T. Akilimali, Pierre Z. Kamangu, Erick N. Mesia, Gauthier K. Kayembe, Jean Marie N. Situakibanza, Hippolyte N. Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study |
title | Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study |
title_full | Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study |
title_fullStr | Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study |
title_full_unstemmed | Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study |
title_short | Incidence and Predictors of Loss to Follow Up among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study |
title_sort | incidence and predictors of loss to follow up among patients living with hiv under dolutegravir in bunia, democratic republic of congo: a prospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025920/ https://www.ncbi.nlm.nih.gov/pubmed/35457498 http://dx.doi.org/10.3390/ijerph19084631 |
work_keys_str_mv | AT bujurogert incidenceandpredictorsoflosstofollowupamongpatientslivingwithhivunderdolutegravirinbuniademocraticrepublicofcongoaprospectivecohortstudy AT akilimalipierrez incidenceandpredictorsoflosstofollowupamongpatientslivingwithhivunderdolutegravirinbuniademocraticrepublicofcongoaprospectivecohortstudy AT kamanguerickn incidenceandpredictorsoflosstofollowupamongpatientslivingwithhivunderdolutegravirinbuniademocraticrepublicofcongoaprospectivecohortstudy AT mesiagauthierk incidenceandpredictorsoflosstofollowupamongpatientslivingwithhivunderdolutegravirinbuniademocraticrepublicofcongoaprospectivecohortstudy AT kayembejeanmarien incidenceandpredictorsoflosstofollowupamongpatientslivingwithhivunderdolutegravirinbuniademocraticrepublicofcongoaprospectivecohortstudy AT situakibanzahippolyten incidenceandpredictorsoflosstofollowupamongpatientslivingwithhivunderdolutegravirinbuniademocraticrepublicofcongoaprospectivecohortstudy |